Germline and somatic genetics of osteosarcoma — connecting aetiology, biology and therapy

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Nature Reviews Endocrinology

• Publication date

  2017-03-24

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1038/nrendo.2017.16PMID 28338660
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Nfib Promotes Metastasis through a Widespread Increase in Chromatin Accessibility.

  2016cited by this paper
• mTOR signaling in osteosarcoma: Oncogenesis and therapeutic aspects (Review).

  2016cited by this paper
• Transcription Factor NFIB Is a Driver of Small Cell Lung Cancer Progression in Mice and Marks Metastatic Disease in Patients

  2016cited by this paper
• Targeting αvβ3 and αvβ5 integrins inhibits pulmonary metastasis in an intratibial xenograft osteosarcoma mouse model

  2016cited by this paper
• Recent advances in targeted therapy for Ewing sarcoma

  2016cited by this paper
• The role of pharmacogenetics in the treatment of osteosarcoma.

  2016cited by this paper
• The pharmacogenomics of osteosarcoma

  2016cited by this paper
• Analysis of Prognostic Factors in High-Grade Osteosarcoma of the Extremities in Children: A 15-Year Single-Institution Experience

  2016cited by this paper
• Chronic Myeloid Leukemia in the Era of Tyrosine Kinase Inhibitors: An Evolving Paradigm of Molecularly Targeted Therapy

  2016cited by this paper
• Exponentially growing osteosarcoma of mandible with acromegaly

  2016cited by this paper
• Acromegaly

  2016cited by this paper
• The anti-cancer activity of the mTORC1/2 dual inhibitor XL388 in preclinical osteosarcoma models

  2016cited by this paper
• Monogenic and polygenic determinants of sarcoma risk: an international genetic study.

  2016cited by this paper
• Risks of first and subsequent cancers among TP53 mutation carriers in the National Cancer Institute Li‐Fraumeni syndrome cohort

  2016cited by this paper
• The clinical significance of changes in ezrin expression in osteosarcoma of children and young adults

  2016cited by this paper
• Increased Expression of microRNA-199b-5p Associates with Poor Prognosis Through Promoting Cell Proliferation, Invasion and Migration Abilities of Human Osteosarcoma

  2016cited by this paper
• Notch Signaling and the Skeleton.

  2016cited by this paper
• Prevalence of Metastasis at Diagnosis of Osteosarcoma: An International Comparison

  2016cited by this paper
• Evaluation of intraarterial and intravenous cisplatin chemotherapy in the treatment of metastatic osteosarcoma using an orthotopic xenograft mouse model

  2016cited by this paper
• Comparison of MAPIE versus MAP in patients with a poor response to preoperative chemotherapy for newly diagnosed high-grade osteosarcoma (EURAMOS-1): an open-label, international, randomised controlled trial

  2016cited by this paper
• Pediatric And Adolescent Osteosarcoma

  2016cited by this paper
• Assessing the Prognostic Significance of Histologic Response in Osteosarcoma: A Comparison of Outcomes on CCG‐782 and INT0133—A Report From the Children's Oncology Group Bone Tumor Committee

  2016cited by this paper
• Germline Mutations in Predisposition Genes in Pediatric Cancer.

  2015cited by this paper
• A Sleeping Beauty forward genetic screen identifies new genes and pathways driving osteosarcoma development and metastasis

  2015cited by this paper
• Infant birthweight and risk of childhood cancer: international population-based case control studies of 40 000 cases.

  2015cited by this paper
• Methotrexate, Doxorubicin, and Cisplatin (MAP) Plus Maintenance Pegylated Interferon Alfa-2b Versus MAP Alone in Patients With Resectable High-Grade Osteosarcoma and Good Histologic Response to Preoperative MAP: First Results of the EURAMOS-1 Good Response Randomized Controlled Trial

  2015cited by this paper
• Unscrambling the genomic chaos of osteosarcoma reveals extensive transcript fusion, recurrent rearrangements and frequent novel TP53 aberrations

  2015cited by this paper
• "Lassie," "Toto," and fellow pet dogs: poised to lead the way for advances in cancer prevention.

  2015cited by this paper
• High Birth Weight Increases the Risk for Bone Tumor: A Systematic Review and Meta-Analysis

  2015cited by this paper
• Prognostic factors for survival in patients with high-grade osteosarcoma using the Surveillance, Epidemiology, and End Results (SEER) Program database.

  2015cited by this paper
• Dual mTORC1/2 inhibition by INK-128 results in antitumor activity in preclinical models of osteosarcoma.

  2015cited by this paper
• Germline TP53 variants and susceptibility to osteosarcoma.

  2015cited by this paper
• Prognostic Factors and Treatment Results of High-Grade Osteosarcoma in Norway: A Scope Beyond the “Classical” Patient

  2015cited by this paper
• Bone cancer incidence by morphological subtype: a global assessment

  2015cited by this paper
• Rapamycin inhibits tumor growth of human osteosarcomas.

  2015cited by this paper
• Sorafenib and everolimus for patients with unresectable high-grade osteosarcoma progressing after standard treatment: a non-randomised phase 2 clinical trial.

  2015cited by this paper
• RUNX2 and the PI3K/AKT axis reciprocal activation as a driving force for tumor progression

  2015cited by this paper
• Sunitinib malate (SU-11248) reduces tumour burden and lung metastasis in an intratibial human xenograft osteosarcoma mouse model.

  2015cited by this paper
• Role of pharmacogenetics of drug-metabolizing enzymes in treating osteosarcoma

  2015cited by this paper
• A Genome-Wide Scan Identifies Variants in NFIB Associated with Metastasis in Patients with Osteosarcoma.

  2015cited by this paper
• Exome sequencing of osteosarcoma reveals mutation signatures reminiscent of BRCA deficiency

  2015cited by this paper
• Understanding the role of Notch in osteosarcoma.

  2014cited by this paper
• Current Advances in Osteosarcoma

  2014cited by this paper
• Recurrent somatic structural variations contribute to tumorigenesis in pediatric osteosarcoma.

  2014cited by this paper
• Wnt Pathway in Osteosarcoma, from Oncogenic to Therapeutic

  2014cited by this paper
• Association of ITGA3 gene polymorphisms with susceptibility and clinicopathological characteristics of osteosarcoma

  2014cited by this paper
• Notch activation as a driver of osteogenic sarcoma.

  2014cited by this paper
• Receptor tyrosine kinases in osteosarcoma: not just the usual suspects.

  2014cited by this paper
• GRM4 gene polymorphism is associated with susceptibility and prognosis of osteosarcoma in a Chinese Han population

  2014cited by this paper
• Association of the vascular endothelial growth factor (VEGF) gene single-nucleotide polymorphisms with osteosarcoma susceptibility in a Chinese population

  2014cited by this paper
• Association of RECQL5 gene polymorphisms and osteosarcoma in a Chinese Han population

  2014cited by this paper
• EURAMOS-1, an international randomised study for osteosarcoma: results from pre-randomisation treatment

  2014cited by this paper
• Translational biology of osteosarcoma

  2014cited by this paper
• Combination of the mTOR Inhibitor Ridaforolimus and the Anti-IGF1R Monoclonal Antibody Dalotuzumab: Preclinical Characterization and Phase I Clinical Trial

  2014cited by this paper
• Complementary genomic approaches highlight the PI3K/mTOR pathway as a common vulnerability in osteosarcoma

  2014cited by this paper
• The prognostic value of elevated ezrin in patients with osteosarcoma

  2014cited by this paper
• Risk of subsequent malignant neoplasms in long-term hereditary retinoblastoma survivors after chemotherapy and radiotherapy.

  2014cited by this paper
• Participation of the Fas/FasL signaling pathway and the lung microenvironment in the development of osteosarcoma lung metastases.

  2014cited by this paper
• Association between CTLA-4 genetic polymorphisms and susceptibility to osteosarcoma in Chinese Han population

  2014cited by this paper
• Association of the Polymorphisms in the Fas/FasL Promoter Regions with Cancer Susceptibility: A Systematic Review and Meta-Analysis of 52 Studies

  2014cited by this paper
• Whole-exome sequencing and functional studies identify RPS29 as a novel gene mutated in multicase Diamond-Blackfan anemia families.

  2014cited by this paper
• Role of ezrin in osteosarcoma metastasis.

  2014cited by this paper
• Inhibition of the Wnt-β-catenin and Notch signaling pathways sensitizes osteosarcoma cells to chemotherapy.

  2013cited by this paper
• Notch Signaling is Associated with ALDH Activity and an Aggressive Metastatic Phenotype in Murine Osteosarcoma Cells

  2013cited by this paper
• Association analysis between genetic variants of MDM2 gene and osteosarcoma susceptibility in Chinese.

  2013cited by this paper
• Genome-wide Association Study Identifies Two Susceptibility Loci for Osteosarcoma

  2013cited by this paper
• Li-Fraumeni syndrome

  2013cited by this paper
• The Prognostic Role of Ezrin Immunoexpression in Osteosarcoma: A Meta-Analysis of Published Data

  2013cited by this paper
• Dkk-3, a Secreted Wnt Antagonist, Suppresses Tumorigenic Potential and Pulmonary Metastasis in Osteosarcoma

  2013cited by this paper
• HES1, a target of Notch signaling, is elevated in canine osteosarcoma, but reduced in the most aggressive tumors

  2013cited by this paper
• Correlation of WWOX, RUNX2 and VEGFA protein expression in human osteosarcoma

  2013cited by this paper
• Prognostic significance of VEGF expression in osteosarcoma: a meta-analysis

  2013cited by this paper
• Runt-related transcription factor 2 (RUNX2) inhibits p53-dependent apoptosis through the collaboration with HDAC6 in response to DNA damage

  2013cited by this paper
• Case-parent analysis of variation in pubertal hormone genes and pediatric osteosarcoma: a Children's Oncology Group (COG) study.

  2012cited by this paper
• Initial testing (stage 1) by the pediatric preclinical testing program of RO4929097, a γ‐secretase inhibitor targeting notch signaling

  2012cited by this paper
• High‐throughput genotyping in osteosarcoma identifies multiple mutations in phosphoinositide‐3‐kinase and other oncogenes

  2012cited by this paper
• Phase II study of the mammalian target of rapamycin inhibitor ridaforolimus in patients with advanced bone and soft tissue sarcomas.

  2012cited by this paper
• Not Just the Usual Suspects

  2012cited by this paper
• Lysyl Oxidase Polymorphisms and Susceptibility to Osteosarcoma

  2012cited by this paper
• mTOR signaling in growth control and disease.

  2012cited by this paper
• Patterns of Bone Sarcomas as a Second Malignancy in Relation to Radiotherapy in Adulthood and Histologic Type

  2012cited by this paper
• At-Risk Populations for Osteosarcoma: The Syndromes and Beyond

  2012cited by this paper
• Association of FGFR3 and MDM2 Gene Nucleotide Polymorphisms with Bone Tumors

  2012cited by this paper
• Incidence of neoplasia in Diamond Blackfan anemia: a report from the Diamond Blackfan Anemia Registry.

  2012cited by this paper
• miR-20a encoded by the miR-17-92 cluster increases the metastatic potential of osteosarcoma cells by regulating Fas expression.

  2012cited by this paper
• An International Comparison

  2012cited by this paper
• Massive Genomic Rearrangement Acquired in a Single Catastrophic Event during Cancer Development

  2011cited by this paper
• Cytotoxic T-Lymphocyte Antigen-4 +49G/A Polymorphism Is Associated with Increased Risk of Osteosarcoma

  2011cited by this paper
• A Systematic Review and Meta-analysis

  2011cited by this paper
• CD86 + 1057G/A Polymorphism and Susceptibility to Osteosarcoma

  2011cited by this paper
• Height at diagnosis and birth-weight as risk factors for osteosarcoma

  2011cited by this paper
• Int7G24A variant of transforming growth factor-beta receptor 1 is associated with osteosarcoma susceptibility in a Chinese population

  2011cited by this paper
• Cytotoxic T-lymphocyte Antigen-4 Polymorphisms and Susceptibility to Osteosarcoma

  2011cited by this paper
• 466 INCIDENCE AND OUTCOMES OF DUCTAL CARCINOMA OF THE PROSTATE: ANALYSIS OF DATA FROM THE SURVEILLANCE, EPIDEMIOLOGY, AND END RESULTS PROGRAM

  2011cited by this paper
• Li-fraumeni syndrome.

  2011cited by this paper
• A comprehensive candidate gene approach identifies genetic variation associated with osteosarcoma

  2011cited by this paper
• Glutathione S-transferase polymorphisms and bone tumor risk in China.

  2011cited by this paper
• Notch signalling in solid tumours: a little bit of everything but not all the time

  2011cited by this paper
• Telomere length and variation in telomere biology genes in individuals with osteosarcoma.

  2011cited by this paper
• Notch signaling in developmental and tumor angiogenesis.

  2011cited by this paper

• Unraveling syndrome-driven osteosarcoma: genetic insights and therapeutic frontiers.

  2026cites this paper
• O PAPEL DOS MACRÓFAGOS M2 ASSOCIADOS A TUMOR NA GÊNESE DO OSTEOSSARCOMA: MECANISMOS INVASIVOS

  2026cites this paper
• Nanoparticles Targeting the Tumor Microenvironment for the Treatment of Osteosarcoma: Recent Progress and Perspectives.

  2026cites this paper
• Age-Stratified Transcriptomic Profiling Reveals Biologically Distinct Molecular Phenotypes Across Pediatric, Adolescent, and Adult Osteosarcoma.

  2026cites this paper
• Global to local burdens, inequalities, and achievable frontiers of child and adolescent malignant neoplasm of bone and articular cartilage across 953 countries and sublocations, 1980–2040, with deep learning-based forecasts

  2026cites this paper
• pH/ROS-responsive magnesium scaffold functionalized via hydrazone bonds for localized postoperative bone tumor therapy.

  2025cites this paper
• Dual-Functional Interface Engineering of Mesoporous Bioactive Glass via Polydopamine Chelation for 3D-Printed Scaffolds with Synergistic Photothermal Therapy and Enhanced Osteogenesis.

  2025cites this paper
• Based on single-cell and transcriptome data, ferroptosis and the immunological landscape in osteosarcoma were discovered

  2025cites this paper
• The Nrf2 Inhibitor Brusatol Promotes Human Osteosarcoma (MG63) Growth and Blocks EB1089-Induced Differentiation

  2025cites this paper
• PHGDH inhibition and FOXO3 modulation drives PUMA-dependent apoptosis in osteosarcoma

  2025cites this paper
• Pathology-interpretable radiomic model for predicting clinical outcome in patients with osteosarcoma: a retrospective, multicenter study

  2025cites this paper
• Construction and clinical validation of a machine-learning-based consensus prognostic signature (MLPS) for osteosarcoma via multi-cohort data integration.

  2025cites this paper
• Recent advances in hydrogel-assisted treatment of malignant bone tumors

  2025cites this paper
• Long non-coding RNAs in osteosarcoma: multifaceted regulators of malignancy and therapeutic resistance

  2025cites this paper
• Demethylase, ALKBH1, regulates osteosarcoma chemosensitivity through FZD8/Wnt/β-catenin signaling pathway in the m7G manner.

  2025cites this paper
• Interrupting ELMSAN1 repression of nuclear acetyl-CoA production therapeutically reprograms cancer cells

  2025cites this paper
• HEY1 promotes the development and metastasis of osteosarcoma through CD44/EGFR/FAK pathway

  2025cites this paper
• MASP1 as a favorable prognostic biomarker in pediatric osteosarcoma: an integrated analysis of machine learning, bioinformatics, and validation experiments

  2025cites this paper
• An improved experimental model of osteosarcoma lung metastases to investigate innovative therapeutic interventions and sex as a biological variable.

  2025cites this paper
• The Anticancer Perspective of Tangeretin: A Small Review

  2025cites this paper
• Exosomal Gene Biomarkers in Osteosarcoma: Mifepristone as a Targeted Therapeutic Revealed by Multi‐Omics Analysis

  2025cites this paper
• SMARCAL1 is a new osteosarcoma predisposition gene.

  2025cites this paper
• Mechanism by which CAP regulates the “cold–heat” balance in osteosarcoma model mice: an integrative study of metabolomics, transcriptomics, and network pharmacology

  2025cites this paper
• Clinical Outcomes and Surgical Procedures for Patients With Osteosarcoma and Metachronous Lung Metastasis: A Chronological Analysis

  2025influential citation
• Smart nanomaterials for multimodal theranostics and tissue regeneration

  2025cites this paper
• Survival profiles and associated factors for overall and cancer specific survival in patients with chondroblast and fibroblastic osteosarcoma

  2025cites this paper
• LncRNA OLMALINC promotes osteosarcoma progression through USP1-mediated autophagy suppression

  2025cites this paper
• Integrins identified as potential prognostic markers in osteosarcoma through multi-omics and multi-dataset analysis

  2025cites this paper
• FGF1 as a New Promising Therapeutic Target in Type 2 Diabetes: Advances in Research and Clinical Trials

  2025cites this paper
• PDK1-dependent metabolic reprogramming regulates stemness and tumorigenicity of osteosarcoma stem cells through ATF3

  2025cites this paper
• Osteosarcoma in Japan: report from the bone and soft tissue tumor registry 2006-2022.

  2025cites this paper
• Global research trends and emerging themes in osteosarcoma metabolomics: a bibliometric and visualization analysis

  2025cites this paper
• Heterogeneity in Osteosarcoma Revealed by scRNA Sequencing: CLU+ Endothelial Cells as Key Players in Tumor Progression

  2025cites this paper
• Androgen-induced AR-BRD4 transcriptional regulatory complex promotes malignant proliferation of osteosarcoma cells

  2025cites this paper
• Identification of cardiotoxic targets of doxorubicin via network toxicology and development of exosome-based delivery system for osteosarcoma therapy.

  2025cites this paper
• Derepressing nuclear pyruvate dehydrogenase induces therapeutic cancer cell reprogramming.

  2025cites this paper
• [Incomplete multimodal bone tumor image classification based on feature decoupling and fusion].

  2025cites this paper
• Endothelial remodeling in osteosarcomas: insights from patient samples and in vitro studies.

  2025cites this paper
• Multifunctional 4D printed shape memory composite scaffolds with photothermal and magnetothermal effects for multimodal tumor therapy and bone repair

  2025cites this paper
• Pathogenesis of osteosarcoma and intervention with traditional chinese medicine

  2025cites this paper
• Magnesium alloy implant with photothermal-enhanced ferroptosis towards a multimodal therapy strategy for osteosarcoma

  2025cites this paper
• A Radiograph Dataset for the Classification, Localization, and Segmentation of Primary Bone Tumors

  2025cites this paper
• Chromoanagenesis in Osteosarcoma

  2025cites this paper
• Downregulation of ferroptosis-related Genes can regulate the invasion and migration of osteosarcoma cells

  2025cites this paper
• Annona muricata Graviola Induces Apoptosis in Two Osteosarcoma Cell Lines and Downregulates the Cytokines IL-6 and TGFβ1 Which Are Implicated in Tumour Growth and Metastasis

  2025cites this paper
• The osteosarcoma immune microenvironment in progression: PLEK as a prognostic biomarker and therapeutic target

  2025cites this paper
• Incomplete Multimodal Bone Tumor Image Classification Based on Attention Fusion and Feature Sharing

  2024cites this paper
• Whole-Exome Analysis and Osteosarcoma: A Game Still Open

  2024cites this paper
• USP5‐dependent HDAC1 promotes cisplatin resistance and the malignant progression of non–small cell lung cancer by regulating RILP acetylation levels

  2024cites this paper
• Novel lipid metabolism factor HIBCH inhibitor synergizes with doxorubicin to suppress osteosarcoma growth and impacts clinical prognosis in osteosarcoma patients

  2024cites this paper
• Natural lung-tropic TH9 cells: a sharp weapon for established lung metastases

  2024cites this paper
• Reconstrução toracoabdominal com tela de polipropileno após exérese de osteossarcoma condroblástico em cadela

  2024cites this paper
• Hyaluronic acid-functionalized ruthenium photothermal nanoenzyme for enhancing osteosarcoma chemotherapy: Cascade targeting and bidirectional modulation of drug resistance.

  2024cites this paper
• Role of non-coding RNA in exosomes for the diagnosis and treatment of osteosarcoma

  2024cites this paper
• Prognostic signature and immunotherapeutic relevance of Focal adhesion signaling pathway-related genes in osteosarcoma

  2024cites this paper
• Crosstalk between O-GlcNAcylation and ubiquitination: a novel strategy for overcoming cancer therapeutic resistance

  2024cites this paper
• Photothermal Catalytic Reduction and Bone Tissue Engineering Towards a Three‐in‐One Therapy Strategy for Osteosarcoma

  2024cites this paper
• Bibliometric analysis and visualisation of research hotspots and frontiers on omics in osteosarcoma

  2024cites this paper
• M2 macrophage exosome‐derived Apoc1 promotes ferroptosis resistance in osteosarcoma by inhibiting ACSF2 deubiquitination

  2024cites this paper
• Electrophoretic deposition of curcumin-loaded mesoporous bioactive glass nanoparticle-chitosan composite coatings on titanium for treating tumor-induced bone defect

  2024cites this paper
• Significance of exosomes in osteosarcoma research: a systematic review and meta-analysis of a singular clinical investigation

  2024cites this paper
• High Expression of miR-218-5p in the Peripheral Blood Stream and Tumor Tissues of Pediatric Patients with Sarcomas

  2024cites this paper
• Polydatin: A natural compound with multifaceted anticancer properties

  2024cites this paper
• Apoptotic Induction by Biosynthesized Gold Nanoparticles Using Phormidesmis communis Strain AB_11_10 against Osteosarcoma Cancer

  2024cites this paper
• RGD-tagging of star-shaped PLA-PEG micellar nanoassemblies enhances doxorubicin efficacy against osteosarcoma.

  2024cites this paper
• Clinical, pathologic and molecular findings in 2 Rottweiler littermates with appendicular osteosarcoma

  2024cites this paper
• Sarcoma incidence worldwide: regional differences in histology and molecular subtypes

  2024cites this paper
• Identification of a pro-protein synthesis osteosarcoma subtype for predicting prognosis and treatment

  2024influential citation
• Chitosan/NH2-MIL-125 (Ti) scaffold loaded with doxorubicin for postoperative bone tumor clearance and osteogenesis: An in vitro study.

  2024cites this paper
• RANK/RANKL axis promotes migration, invasion, and metastasis of osteosarcoma via activating NF-κB pathway.

  2024cites this paper
• Osteosarcoma through the Lens of Bone Development, Signaling, and Microenvironment.

  2024cites this paper
• Sex differences in osteosarcoma survival across the age spectrum: A National Cancer Database analysis (2004-2016).

  2024cites this paper
• Establishment of a prognostic risk model for osteosarcoma and mechanistic investigation

  2024cites this paper
• Importance of CD8 Tex cell-associated gene signatures in the prognosis and immunology of osteosarcoma

  2024cites this paper
• Nanoengineered 3D-printing scaffolds prepared by metal-coordination self-assembly for hyperthermia-catalytic osteosarcoma therapy and bone regeneration.

  2024cites this paper
• An immune-related eleven-RNA signature-drived risk score model for prognosis of osteosarcoma metastasis

  2024cites this paper
• Concerting magnesium implant degradation facilitates local chemotherapy in tumor-associated bone defect

  2024cites this paper
• MgSiO3 Fiber Membrane Scaffold with Triggered Drug Delivery for Osteosarcoma Synergetic Therapy and Bone Regeneration.

  2024cites this paper
• A novel classification predicts prognosis and drug sensitivity in osteosarcoma based on alterations in gene sets

  2024cites this paper
• Unveiling the Protective Role of Melatonin in Osteosarcoma: Current Knowledge and Limitations

  2024cites this paper
• Preclinical models for the study of pediatric solid tumors: focus on bone sarcomas

  2024cites this paper
• Unraveling molecular aberrations and pioneering therapeutic strategies in osteosarcoma.

  2024cites this paper
• In vivo therapy of osteosarcoma using anion transporters-based supramolecular drugs

  2024cites this paper
• Targeted anti-angiogenesis therapy for advanced osteosarcoma

  2024cites this paper
• Recent advances of m6A methylation in skeletal system disease

  2024cites this paper
• Osteosarcoma and Langerhans Cell Histiocytosis in a Pediatric Patient with Lynch Syndrome

  2024cites this paper
• Survival and prognostic factors in pediatric osteosarcoma: A 5-year single-center experience in Central Java, Indonesia

  2024cites this paper
• LncRNA HOXA-AS3 promotes cell proliferation and invasion via targeting miR-218-5p/FOXP1 axis in osteosarcoma

  2024cites this paper
• CDK4 is co-amplified with either TP53 promoter gene fusions or MDM2 through distinct mechanisms in osteosarcoma

  2024cites this paper
• UK guidelines for the management of bone sarcomas

  2024cites this paper
• Identification and validation of novel biomarkers associated with immune infiltration for the diagnosis of osteosarcoma based on machine learning

  2023cites this paper
• A novel ferroptosis-related microRNA signature with prognostic value in osteosarcoma

  2023cites this paper
• Bone-targeting exosome nanoparticles activate Keap1 / Nrf2 / GPX4 signaling pathway to induce ferroptosis in osteosarcoma cells

  2023cites this paper
• Genetically inferred birthweight, height, and puberty timing and risk of osteosarcoma.

  2023influential citation
• Prognostic and immunological significance of an M1 macrophage-related gene signature in osteosarcoma

  2023cites this paper
• Analysis of the Mutational Landscape of Osteosarcomas Identifies Genes Related to Metastasis and Prognosis and Disrupted Biological Pathways of Immune Response and Bone Development

  2023influential citation
• Dog breeds and conformations predisposed to osteosarcoma in the UK: a VetCompass study

  2023cites this paper
• Identification and validation of long noncoding RNA AC083900.1 and RP11-283C24.1 for prediction of progression of osteosarcoma.

  2023cites this paper
• Chemotherapy Regimens for Non-Metastatic Conventional Appendicular Osteosarcoma: A Literature Review Based on the Outcomes

  2023cites this paper
• Resveratrol Loaded by Folate-Modified Liposomes Inhibits Osteosarcoma Growth and Lung Metastasis via Regulating JAK2/STAT3 Pathway

  2023cites this paper